0.00Open0.03Pre Close0 Volume7.94K Open Interest2.00Strike Price0.00Turnover771.66%IV173.95%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type0.1471Delta0.4390Gamma24.72Leverage Ratio-0.0177Theta0.0000Rho3.64Eff Leverage0.0002Vega
Ocugen Stock Discussion
MALVERN, Pa., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced a positive 2-year safety and efficacy update for the Phase 1...
Ocugen, Inc. Announces Positive 2-Year Data Across Multiple Mutations from Phase 1/2 Clinical Trial of OCU400 —A Novel Modifier Gene Therapy for Retinitis Pigmentosa
Monday, 13th January at 6:30 am
• 100% (9/9) of treated evaluable subjects demonstrated improvement or preservation in visual function compared to untreated eyes at both one and two years
• 100% (9/9) of treated evaluable subjects demonstrated improvement or stabilization in mobility testing, which was only p...
$SEALSQ Corp (LAES.US)$
been watching this one for a year ocugen. they are a very promising company. they have a lot of good thingsdue to start making profit in 2026. do your research you might be interested... chart doesn't look nice but that's because they been in a trial stages. but 2026 the profit year. big hedgefunds been buying up recently... Just sharing some of my personal stock picks.
FUCKING finally.
No comment yet